Effects of a new oral hypoglycaemic agent, repaglinide, on metabolic control in sulphonylurea-treated patients with NIDDM - Concepedia

Concepedia

Publication | Closed Access

Effects of a new oral hypoglycaemic agent, repaglinide, on metabolic control in sulphonylurea-treated patients with NIDDM

84

Citations

8

References

1993

Year

Bruce H. R. Wolffenbuttel, L. Nijst, J P Sels, P. P. C. A. Menheere, P. M�ller, A. C. Nieuwenhuijzen Kruseman

European Journal of Clinical Pharmacology

Metabolic SyndromeMedicineDiabetesClinical PharmacologyMetabolic ControlPharmacotherapyMetabolismPharmacologySulphonylurea-treated Patients

References

	Year	Citations

Page 1